tolvaptan has been researched along with pasireotide in 1 studies
Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (pasireotide) | Trials (pasireotide) | Recent Studies (post-2010) (pasireotide) |
---|---|---|---|---|---|
967 | 172 | 786 | 425 | 86 | 341 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harris, PC; Hommerding, CJ; Hopp, K; Torres, VE; Wang, X; Ye, H | 1 |
1 other study(ies) available for tolvaptan and pasireotide
Article | Year |
---|---|
Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model.
Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cell Line, Tumor; Cell Membrane; Cyclic AMP; Deamino Arginine Vasopressin; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microsatellite Repeats; Models, Genetic; Polycystic Kidney, Autosomal Dominant; Somatostatin; Tolvaptan; TRPP Cation Channels | 2015 |